AtriCure gets FDA OK for Synergy ablation system

12/19/2011 | Reuters

The FDA has granted AtriCure approval for its Synergy ablation device for use in treating patients with atrial fibrillation during open-heart procedures. The Synergy system is the first such device to have been cleared for atrial fibrillation therapy in the U.S.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ